1096Impact of Universal Pneumococal Vaccination in Children in Argentina

بررسی میزان پوشش واکسیناسیون کودکان 14- 12 ماهه در مناطق تحت پوشش دانشگاه علوم پزشکی و خدمات بهداشتی درمانی ایران - خرداد 1376

Today, the iive s of more than 3000000 children are protected by immun ization services in the from of EPI (expanded program of immunization). This program helps ideal growth and development for mlliotis of children, but in spite of current EPI , preventable diseases are still able to take the lives innocent children. Cause specific mortality rates of children, due to preventable diseases, show...

Community Acquired Pneumonia Incidence Among Children Under 5 Years of Age in Concordia Argentina. Universal Vaccination Impact

Public health and economic benefits of new pediatric influenza vaccination programs in Argentina

BACKGROUND Argentina's population was heavily affected by the 2009 influenza pandemic, particularly children, in whom incidence of seasonal influenza is consistently high. Following the pandemic, Argentinean national recommendations for pediatric vaccination against A/H1N1 influenza were defined for all children aged up to five years, in line with programs implemented by national authorities el...

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

Background The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making.   Methods Two previously published models delivering outputs in QALYs, were adapted...

Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina.

UNLABELLED Due to the region's own conditions, universal vaccination with pneumococcal conjugate heptavalent vaccine (PCV-7) in Latin American countries is still controversial. OBJECTIVE To compare projected economic costs and health benefits associated with pneumococcal conjugate heptavalent vaccine as a routine immunization in healthy children in Argentina. DESIGN A decision analytic mode...